Assertio increases full-year net product sales outlook to in excess of $152 million

Lake forest, ill., dec. 05, 2022 (globe newswire) -- assertio holdings, inc. (“assertio” or the “company”) (nasdaq: asrt), a specialty pharmaceutical company offering differentiated products to patients, today announced that it is raising its outlook for 2022 full-year net product sales to greater than $152 million, increased from its prior outlook calling for net product sales of greater than $141 million for the full year. the company noted that net product sales to date in the fourth quarter have significantly exceeded its prior expectations used in formulating the company's outlook provided with its third quarter results on november 8, 2022.
ASRT Ratings Summary
ASRT Quant Ranking